Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
about
Impaired Fracture Healing Caused by Deficiency of the Immunoreceptor Adaptor Protein DAP12.Denosumab in postmenopausal osteoporosis: what the clinician needs to know.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Local delivery of osteoprotegerin inhibits mechanically mediated bone modeling in orthodontic tooth movementEmerging treatments for postmenopausal osteoporosis - focus on denosumab.RANKL inhibition for the management of patients with benign metabolic bone disorders.The effect of osteoprotegerin on implant osseointegration in ovariectomized rats.The role and efficacy of denosumab in the treatment of osteoporosis: an update.Overview of skeletal repair (fracture healing and its assessment).Orthobiologics in the augmentation of osteoporotic fractures.Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model.
P2860
Q35648310-E80257E9-189F-4498-B338-7F55348451D1Q36056922-7691CAB5-7BF8-41F3-BABD-6958427E8F15Q36860987-B83DB564-6A03-4CE3-9C2C-C1C1C94A9304Q36968961-C6C8DA7F-D131-417B-A02D-AD601FF01395Q37230477-788A22B6-D93E-4AA5-BE2B-18ACAEDA97DBQ37532561-B6CD24FD-7AF9-4912-BD5D-57D7ECC1DEF5Q37675603-F65D7C4E-C250-45E8-A939-09F9E38B9B83Q37826197-A6832857-82FA-4BB6-B34C-30EA91E7F2B3Q38183792-704E736E-23E1-4C6A-845C-4D721B09091AQ38272234-4BB3F0B9-DDCC-4BB1-B23E-C4898B11F88AQ46294640-73F46731-D7D6-48F9-941F-CEF82C26A783
P2860
Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Osteoprotegerin treatment impa ...... structural fracture strength.
@ast
Osteoprotegerin treatment impa ...... structural fracture strength.
@en
type
label
Osteoprotegerin treatment impa ...... structural fracture strength.
@ast
Osteoprotegerin treatment impa ...... structural fracture strength.
@en
prefLabel
Osteoprotegerin treatment impa ...... structural fracture strength.
@ast
Osteoprotegerin treatment impa ...... structural fracture strength.
@en
P1476
Osteoprotegerin treatment impa ...... structural fracture strength.
@en
P2093
Andreassen TT
Ulrich-Vinther M
P2888
P304
P356
10.1007/S00223-004-0126-9
P407
P577
2005-04-11T00:00:00Z
P6179
1043209162